Healthcare provider profile · identity verified

Peter Cooper Reyner, MD

Internal Medicine · TEMPLE, PA · NPI 1285620013

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	867	237
Atorvastatin Calcium	Atorvastatin Calcium	726	214
Hydrochlorothiazide	Hydrochlorothiazide	430	137
Losartan Potassium	Losartan Potassium	393	123
Levothyroxine Sodium	Levothyroxine Sodium	390	103
Metoprolol Succinate	Metoprolol Succinate	334	97
Omeprazole	Omeprazole	292	96
Metformin Hcl	Metformin Hcl	236	71
Simvastatin	Simvastatin	232	63
Pantoprazole Sodium	Pantoprazole Sodium	208	61
Tamsulosin Hcl	Tamsulosin Hcl	208	63
Eliquis	Apixaban	189	45
Potassium Chloride	Potassium Chloride	185	56
Lisinopril	Lisinopril	176	54
Furosemide	Furosemide	173	58
Sertraline Hcl	Sertraline Hcl	171	47
Alprazolam	Alprazolam	151	40
Pravastatin Sodium	Pravastatin Sodium	142	40
Lorazepam	Lorazepam	139	32
Rosuvastatin Calcium	Rosuvastatin Calcium	139	46
Ozempic	Semaglutide	128	28
Allopurinol	Allopurinol	124	36
Albuterol Sulfate Hfa	Albuterol Sulfate	115	39
Metoprolol Tartrate	Metoprolol Tartrate	108	33
Gabapentin	Gabapentin	106	33
Metformin Hcl Er	Metformin Hcl	98	28
Xarelto	Rivaroxaban	93	17
Tramadol Hcl	Tramadol Hcl	92	16
Oxycodone Hcl	Oxycodone Hcl	88	13
Pregabalin	Pregabalin	83	21
Glipizide Er	Glipizide	81	24
Chlorthalidone	Chlorthalidone	80	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	80	27
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	76	suppressed
Duloxetine Hcl	Duloxetine Hcl	75	21
Clopidogrel	Clopidogrel Bisulfate	74	26
Famotidine	Famotidine	70	16
Fluticasone Propionate	Fluticasone Propionate	67	30
Synthroid	Levothyroxine Sodium	66	17
Meloxicam	Meloxicam	62	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	58	19
Venlafaxine Hcl Er	Venlafaxine Hcl	57	13
Esomeprazole Magnesium	Esomeprazole Magnesium	55	15
Prednisone	Prednisone	55	40
Trazodone Hcl	Trazodone Hcl	53	12
Jardiance	Empagliflozin	51	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	51	12
Zolpidem Tartrate	Zolpidem Tartrate	51	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	50	17
Irbesartan	Irbesartan	50	suppressed
Atenolol	Atenolol	49	14
Klor-Con M20	Potassium Chloride	48	17
Doxycycline Hyclate	Doxycycline Hyclate	47	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	47	13
Alendronate Sodium	Alendronate Sodium	46	15
Naproxen	Naproxen	46	17
Bupropion Xl	Bupropion Hcl	44	12
Celecoxib	Celecoxib	43	suppressed
Azithromycin	Azithromycin	42	36
Clonazepam	Clonazepam	42	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	42	13
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	42	16
Ventolin Hfa	Albuterol Sulfate	42	16
Mounjaro	Tirzepatide	41	suppressed
Torsemide	Torsemide	41	12
Breo Ellipta	Fluticasone/Vilanterol	39	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	37	12
Escitalopram Oxalate	Escitalopram Oxalate	35	13
Bisoprolol Fumarate	Bisoprolol Fumarate	34	11
Citalopram Hbr	Citalopram Hydrobromide	34	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	34	suppressed
Glipizide	Glipizide	33	suppressed
Ezetimibe	Ezetimibe	32	suppressed
Paroxetine Hcl	Paroxetine Hcl	32	11
Nitroglycerin	Nitroglycerin	31	suppressed
Diazepam	Diazepam	29	suppressed
Ramipril	Ramipril	29	suppressed
Trulicity	Dulaglutide	29	suppressed
Montelukast Sodium	Montelukast Sodium	28	suppressed
Nifedipine Er	Nifedipine	28	suppressed
Labetalol Hcl	Labetalol Hcl	26	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	19
Triamcinolone Acetonide	Triamcinolone Acetonide	26	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	25	suppressed
Mirtazapine	Mirtazapine	25	suppressed
Mometasone Furoate	Mometasone Furoate	25	12
Tizanidine Hcl	Tizanidine Hcl	25	11
Valsartan	Valsartan	25	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	24	suppressed
Spironolactone	Spironolactone	24	11
Carbamazepine	Carbamazepine	23	suppressed
Carvedilol	Carvedilol	23	suppressed
Cephalexin	Cephalexin	23	20
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Tresiba Flextouch U-100	Insulin Degludec	21	suppressed
Latanoprost	Latanoprost	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	17
Estradiol	Estradiol	19	suppressed
Finasteride	Finasteride	19	suppressed
Lactulose	Lactulose	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Nebivolol Hcl	Nebivolol Hcl	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	18	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	18	suppressed
Methylprednisolone	Methylprednisolone	18	16
Morphine Sulfate Er	Morphine Sulfate	18	suppressed
True Comfort Safety Pen Needle	Pen Needle, Diabetic, Safety	18	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	18	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	17	suppressed
Felodipine Er	Felodipine	17	suppressed
Fluconazole	Fluconazole	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Glimepiride	Glimepiride	15	suppressed
Nateglinide	Nateglinide	15	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	15	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	15	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Digoxin	Digoxin	13	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Klor-Con M10	Potassium Chloride	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Risperidone	Risperidone	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Amiloride Hcl	Amiloride Hcl	11	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Linzess	Linaclotide	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed
Premarin	Estrogens, Conjugated	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error